Dew, I'm violating scientific principles here because of my personal observations and niacin results (ie. my niacin regimen has lowered my LDL and raised my HDL much better than using simvaststin), so I'll lay 4 to 1 odds that the Niaspan was superior.
What I'd like to get opinions on is just how much of an increase in Niaspan prescriptions a positive outcome from the study will provide. Do we have any models for comparing a prescription form of an OTC health aid readily available to the public?
Market Data 
Markets 
AI
